Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)
Trial Summary
What is the purpose of this trial?
This trial will test if a single injection of cells taken from a man's own fat tissue can safely and effectively treat erectile dysfunction. It aims to help men who do not respond well to standard treatments by improving blood flow and repairing tissue. The cells have been investigated for their potential to treat erectile dysfunction by creating a pro-repair environment at the site of injury.
Do I have to stop taking my current medications for the trial?
Yes, you will need to stop taking any PDE5 inhibitors (medications for erectile dysfunction) for the duration of the study. If you are currently taking blood thinners, cancer drugs, or HIV drugs, you cannot participate in the trial.
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single injection of autologous adipose-derived stromal vascular fraction (SVF)
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term follow-up
Monitoring of adverse events
Treatment Details
Interventions
- GID SVF-2
Find a Clinic Near You
Who Is Running the Clinical Trial?
GID BIO, Inc.
Lead Sponsor